Nanoviricides Inc (NNVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,900 | 18,393 | 21,792 | 13,709 | 6,106 |
| TOTAL | $23,231 | $18,487 | $22,025 | $13,986 | $6,437 |
| Non-Current Assets | |||||
| PPE Net | 9,174 | 9,238 | 9,404 | 9,544 | 9,713 |
| Intangibles | 352 | 354 | 356 | 358 | 361 |
| Other Non-Current Assets | 4 | 6 | 63 | 26 | 17 |
| TOTAL | $9,530 | $9,598 | $9,824 | $9,929 | $10,091 |
| Total Assets | $32,761 | $28,085 | $31,848 | $23,914 | $16,528 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 166 | N/A | 16 | 63 | 109 |
| Accounts payable and accrued liabilities | 681 | 314 | 696 | 942 | 988 |
| Accrued Expenses | 24 | 25 | 62 | 69 | 44 |
| TOTAL | $871 | $339 | $1,866 | $2,156 | $2,213 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $871 | $339 | $1,866 | $2,156 | $2,213 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,505 | 10,677 | 10,665 | 10,654 | 9,073 |
| Common Shares | 12 | 11 | 11 | 9 | 8 |
| Retained earnings | -112,312 | -110,204 | -107,874 | -105,563 | -103,689 |
| TOTAL | $31,890 | $27,746 | $29,982 | $21,758 | $14,315 |
| Total Liabilities And Equity | $32,761 | $28,085 | $31,848 | $23,914 | $16,528 |